Topic: personnel announcements
Allergan taps Celgene vet Bob Hugin for M&A guidance; Imara gains a Pfizer rare disease exec as CMO; and iTeos brings on Sanofi cancer VP as CMO.
Sickle cell disease biotech Imara has nabbed Pfizer’s clinical rare disease lead Willem H. Scheele, M.D., as its new chief medical officer.
COO Charles Ruban and CDO Laurent Martin are both set to leave their positions at the end of next week.
Moroney will step down as CEO after his current contract expires in June 2020, or earlier if a successor is appointed before that time.
João Siffert, M.D., has been given the permanent CEO job at Abeona Therapeutics after serving as interim chief.
Major changes are afoot at AstraZeneca as it shakes up its research structure with new units, new names and big moves.
AbbVie streamlines management team; FDA taps Flatiron exec for oversight post; and PPD beefs up therapeutics team with new leadership.
Abeona CEO Carsten Thiel has been summarily sacked after an investigation into “allegations of misconduct towards colleagues.”
Digital therapeutics company Click has been on a small hiring spree, bringing new medical and regulatory execs into the fold.
Citoxlab, a CRO for nonclinical research, has tapped Christophe Berthoux as chief executive for its European operations.